Recent data show that GLP-1 prescriptions for weight loss have surged, with usage increasing nearly 587 % between 2019 and 2024 , reflecting strong ongoing GLP-1 demand in the U.S
People with type 1 diabetes, particularly those with concomitant chronic kidney disease, are at higher risk of hypoglycaemia, which should be avoided by careful insulin and carbohydrate matching [129]
Lack of data on biomarkers of alcohol consumption, genetic polymorphisms as a determinant of therapeutic response, and change in body composition during the therapy
We appreciate your ongoing commitment to the care of your patients and our members
The understanding is evolving rapidly, and new strategies for successful maintenance are emerging from both clinical research and real-world experience
I expect that the effective doses of oral Wegovy will be much more expensive than the advertised $149, unfortunately